Gain-of-function complement C2 mutant as a supporter of anti-CD20 therapy in murine lymphoma model

2018/29/N/NZ6/01413

Keywords

Descriptors

  • NZ6_1: Odporność swoista i nieswoista
  • NZ6_2: Immunologia kliniczna

Panel

NZ6 – Human and animal immunology and infection: immunity, immune disorders, immunotherapy, infectious and invasive diseases, microbiology, transplantology, allergology

Host institution

Gdański Uniwersytet Medyczny, Międzyuczelniany Wydział Biotechnologii Uniwersytetu Gdańskiego i Gdańskiego Uniwersytetu Medycznego

Voivodeship: pomorskie

Other projects carried out by the institution »

Principal investigator (from the host institution)

Aleksandra Urban

Number of co-investigators in the project: 2

Call

PRELUDIUM 15 – announced on 2018-03-15

Amount awarded
210 000 PLN
Project start date
2019-03-06
Project end date
2022-03-05
Project duration
36 months (the same as in the proposal)
Project status
Project settled

Project description

Download the project description in a pdf file

Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.

Information in the final report

Publication in academic press/journals (1)

  1. In Silico Designed Gain-of-Function Variants of Complement C2 Support Cytocidal Activity of Anticancer Monoclonal Antibodies

    Authors:
    Aleksandra Urban, Alan Majeranowski, Grzegorz Stasiłojć , Patrycja Koszałka, Anna Felberg, Michał Taszner, Jan M Zaucha, Marcin Okrój
    Academic press:
    Cancers (Basel) (year: 2022, volume: 14, pages: 5), Publisher: MDPI
    Status:
    Published
    DOI:
    10.3390/cancers14051270 – link to the publication

« New search

Graphic design and implementation: Jakub Piotrowski